{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T16:08:47Z","timestamp":1781366927730,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bundeswehrkrankenhaus Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic subdural hematoma is a persistent, bloody to serous fluid retention in the subdural space between the dura mater and arachnoid mater, usually caused by an initial trauma, and is one of the most common traumatic intracranial hemorrhages in western industrialized nations. In the event of a compressive effect on the brain, the hematoma is usually relieved by means of a burr hole trephination. In view of the high postoperative recurrence rate, conservative treatment methods have been investigated both as a competitor to surgery alone in cases where the indication for surgery is debatable and as a supportive therapy for surgical hematoma relief. Studies on embolization of the middle meningeal artery during surgery as well as studies on postoperative drug therapy using tranexamic acid have shown the most promise. However, there is currently a lack of studies that randomly compare the effectiveness of these two perioperative treatment strategies regarding to their efficacy in avoiding revision surgery and the safety of the respective procedure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>TABASCO is a prospective, randomized, two-arm, multicenter, clinical trial designed to determine whether postoperative treatment of chronic subdural hematomas using adjuvant drug therapy with tranexamic acid (test group) is equivalent to postoperative embolization of the arteria meningea media (control group) in terms of postoperative volume reduction of the hematoma and the need for revision surgery of CSDH. Patients over 18\u00a0years of age who have undergone surgery for CSDH for the first time no more than 24\u00a0h before inclusion in the study will be randomized 1:1 to the test group or control group. The primary endpoint is the postoperative volume decrease of a primarily surgically relieved CSDH quantitatively and regarding to the time course on the affected side in a study period of 3\u00a0months postoperatively. The secondary endpoint of this study is to investigate the extent to which the rate of necessary revision surgery can be influenced by the adjuvant therapy procedures over the course of 3\u00a0months. The tertiary endpoint is the neurological outcome of the patients included in the study and assigned to the different treatment arms after a total follow-up period of 3\u00a0months as well as the complication rate of the adjuvant procedures used. Assuming a risk difference of 8% for rebleeding and surgical revision, with an applied power of 80%, 276 patients (138 per group) will be included in this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The TABASCO study will provide clinical evidence as to whether embolization of the middle meningeal artery in addition to surgery is comparable to postoperative drug therapy using tranexamic acid as an adjuvant treatment method for operated chronic subdural hematomas in terms of hematoma volume reduction, revision rate and safety of the procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>German Clinical Trials Registry (Deutsches Register Klinischer Studien (DRKS)) DRKS00033515. Registered on 05 Feb 2024.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-08888-6","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:43:27Z","timestamp":1749887007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tranexamic acid vs. embolization of the meningeal artery as an adjunctive therapeutic regime to reduce the recurrence rate after surgical relief of chronic subdural hematomas (TABASCO)\u2014a randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3344-8759","authenticated-orcid":false,"given":"Magnus","family":"Scheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Beuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Max","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Efinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"20","key":"8888_CR1","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa2313472","volume":"391","author":"JM Davies","year":"2024","unstructured":"Davies JM, Knopman J, Mokin M, Hassan AE, Harbaugh RE, Khalessi A, Fiehler J, Gross BA, Grandhi R, Tarpley J, Sivakumar W, Bain M, Crowley RW, Link TW, Fraser JF, Levitt MR, Chen PR, Hanel RA, Bernard JD, Jumaa M, Youssef P, Cress MC, Chaudry MI, Shakir HJ, Lesley WS, Billingsley J, Jones J, Koch MJ, Paul AR, Mack WJ, Osbun JW, Dlouhy K, Grossberg JA, Kellner CP, Sahlein DH, Santarelli J, Schirmer CM, Singer J, Liu JJ, Majjhoo AQ, Wolfe T, Patel NV, Roark C, Siddiqui AH, EMBOLISE Investigators. Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma. N Engl J Med. 2024;391(20):1890\u2013900.","journal-title":"N Engl J Med."},{"issue":"1","key":"8888_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10143-023-01991-9","volume":"46","author":"M de Paula","year":"2023","unstructured":"de Paula M, Ribeiro BDC, Melo MM, de Freitas PVV, Pahl FH, de Oliveira MF, et al. Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial. Neurosurg Rev. 2023;46(1):90.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"8888_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","volume":"14","author":"E Edlmann","year":"2017","unstructured":"Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14(1):108.","journal-title":"J Neuroinflammation"},{"key":"8888_CR4","unstructured":"European Medicines Agency (EMA). Guideline on missing data in confirmatory clinical trials. 2011; 1\u201312."},{"key":"8888_CR5","unstructured":"Fachinformation Cyklokapron \u00ae, 500 mg Filmtabletten, MEDA Pharma GmBH und Co. KG, 07\/2016: 1\u20133."},{"key":"8888_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.wneu.2020.06.140","volume":"141","author":"J Feghali","year":"2020","unstructured":"Feghali J, Yang W, Huang J. Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome. World Neurosurg. 2020;141:339\u201345.","journal-title":"World Neurosurg"},{"issue":"9","key":"8888_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJMoa2409845","volume":"392","author":"D Fiorella","year":"2025","unstructured":"Fiorella D, Monteith SJ, Hanel R, Atchie B, Boo S, McTaggart RA, Zauner A, Tjoumakaris S, Barbier C, Benitez R, Spelle L, Pierot L, Hirsch JA, Froehler M, Arthur AS, STEM Investigators. Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma. N Engl J Med. 2025;392(9):855\u201364.","journal-title":"N Engl J Med."},{"issue":"4","key":"8888_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.59.4.388","volume":"59","author":"H Fujisawa","year":"1995","unstructured":"Fujisawa H, Ito H, Kashiwagi S, Nomura S, Toyosawa M. Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation. J Neurol Neurosurg Psychiatry. 1995;59(4):388\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8888_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archneur.1989.00520420080026","volume":"46","author":"LB Goldstein","year":"1989","unstructured":"Goldstein LB, Bertels C, Davis JN. Interrater reliability of NIH stroke scale. Arch Neurol. 1989;46:660\u20132.","journal-title":"Arch Neurol"},{"issue":"2","key":"8888_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3171\/2022.5.JNS22664","volume":"138","author":"K Hibahashi","year":"2022","unstructured":"Hibahashi K, Ohbe H, Yasunaga H. Adjuvant oral tranexamic acid and reoperation after burr hole surgery in patients with chronic subdural hematoma: propensity score-matched analysis using a nationwide inpatient database. J Neurosurg. 2022;138(2):430\u20136.","journal-title":"J Neurosurg"},{"issue":"1","key":"8888_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s13063-022-06506-3","volume":"23","author":"A Hoenning","year":"2022","unstructured":"Hoenning A, Lemcke J, Rot S, Stengel D, Hoppe B, Zappel K, Schuss P, Mutze S, Goelz L. Middle Meningeal Artery Embolization Minimizes Burdensome Recurrence Rates After Newly Diagnosed Chronic Subdural Hematoma Evacuation (MEMBRANE): study protocol for a randomized controlled trial. Trials. 2022;23(1):703.","journal-title":"Trials"},{"issue":"1","key":"8888_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13063-021-05907-0","volume":"23","author":"S Immenga","year":"2022","unstructured":"Immenga S, Lodewijkx R, Roos YBWEM, Middeldorp S, Majoie CBLM, Willems HC, Vandertop WP, Verbaan D. Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial. Trials. 2022;23(1):56.","journal-title":"Trials."},{"issue":"3","key":"8888_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/2014.5.JNS132715","volume":"121","author":"W Liu","year":"2014","unstructured":"Liu W, Bakker NA, Groen RJM. Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg. 2014;121(3):665\u201373.","journal-title":"J Neurosurg"},{"issue":"18","key":"8888_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.12659\/AJCR.904117","volume":"15","author":"R Mikkelsen","year":"2017","unstructured":"Mikkelsen R, Anker-M\u00f8ller T, Hvas AM, Sunde N. A Case of Tranexamic Acid as Adjunctive Treatment for Chronic Subdural Hematoma with Multiple Recurrences. Am J Case Rep. 2017;15(18):995\u20139.","journal-title":"Am J Case Rep"},{"issue":"5","key":"8888_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3171\/2017.6.JNS17130","volume":"129","author":"R Motiei-Langroudi","year":"2018","unstructured":"Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation. J Neurosurg. 2018;129(5):1143\u201350.","journal-title":"J Neurosurg"},{"issue":"7","key":"8888_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/neurintsurg-2019-015421","volume":"12","author":"S Ng","year":"2020","unstructured":"Ng S, Derraz I, Boetto J, Dargazanli C, Poulen G, Gascou G, Lefevre PH, Molinari N, Lonjon N, Costalat V. Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg. 2020;12(7):695\u20139.","journal-title":"J Neurointerv Surg"},{"issue":"100300","key":"8888_CR17","first-page":"1","volume":"1","author":"A Nouri","year":"2021","unstructured":"Nouri A, Gondar R, Schaller K, Meling T. Chronic Subdural Hematoma (cSDH): A review of the current state of the art. Brain Spine. 2021;1(100300):1\u20139.","journal-title":"Brain Spine"},{"issue":"1","key":"8888_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10143-012-0396-z","volume":"36","author":"S Ohba","year":"2013","unstructured":"Ohba S, Kinoshita Y, Nakagawa T, Murakami H. The risk factors for recurrence of chronic subdural hematoma. Neurosurg Rev. 2013;36(1):145\u201350.","journal-title":"Neurosurg Rev"},{"issue":"3","key":"8888_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/neurintsurg-2021-017450","volume":"14","author":"C Onyinzo","year":"2022","unstructured":"Onyinzo C, Berlis A, Abel M, Kudernatsch M, Maurer CJ. Efficacy and midterm outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone. J Neurointerv Surg. 2022;14(3):297\u2013300.","journal-title":"J Neurointerv Surg"},{"issue":"8","key":"8888_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00117-022-01038-y","volume":"62","author":"W Reith","year":"2022","unstructured":"Reith W, Garner M. Middle meningeal artery embolization for chronic subdural hematomas. Radiologie (Heidelb). 2022;62(8):641\u20137.","journal-title":"Radiologie (Heidelb)"},{"key":"8888_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neurosurgery\/21.CN_suppl_1.1","volume":"21","author":"J Schwarz","year":"2021","unstructured":"Schwarz J, Carnevale JA, Goldberg JL, Ramos AD, Link TW, Knopman J. Perioperative prophylactic middle meningeal artery embolization for chronic subdural hematoma: a series of 44 cases. J Neurosurg. 2021;21:1\u20139.","journal-title":"J Neurosurg"},{"key":"8888_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/neurintsurg-2020-016048","volume":"12","author":"E Shotar","year":"2020","unstructured":"Shotar E, Meyblum L, Premat K, et al. Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerv Surg. 2020;12:1209\u201313.","journal-title":"J Neurointerv Surg"},{"issue":"12","key":"8888_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00701-005-0616-1","volume":"147","author":"M Stanisic","year":"2005","unstructured":"Stanisic M, Lund-Johansen M, Mahesparan R. Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir (Wien). 2005;147(12):1249\u201356.","journal-title":"Acta Neurochir (Wien)"},{"key":"8888_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0036-1584212","volume":"77","author":"JM Stary","year":"2016","unstructured":"Stary JM, Hutchins L, Vega RA. Tranexamic acid for recurring subdural hematomas following surgical evacuation: a clinical case series. J Neurol Surg A. 2016;77:422\u20136.","journal-title":"J Neurol Surg A"},{"issue":"Pt A","key":"8888_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jocn.2020.10.053","volume":"82","author":"KR Wan","year":"2020","unstructured":"Wan KR, Qiu L, Saffari SE, Khong WXL, Ong JCL, See AA, Ng WH, King NKK. An open label randomized trial to assess the efficacy of tranexamic acid in reducing post-operative recurrence of chronic subdural haemorrhage. J Clin Neurosci. 2020;82(Pt A):147\u201354.","journal-title":"J Clin Neurosci"},{"key":"8888_CR26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","volume":"33","author":"JTL Wilson","year":"2002","unstructured":"Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33:2243\u20136.","journal-title":"Stroke"},{"key":"8888_CR27","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/j.wneu.2019.10.134","volume":"134","author":"T Yamada","year":"2020","unstructured":"Yamada T, Natori Y. Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery. World Neurosurg. 2020;134:e549\u201353.","journal-title":"World Neurosurg"},{"issue":"4","key":"8888_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3340\/jkns.2022.0200","volume":"66","author":"K Yang","year":"2023","unstructured":"Yang K, Kim KH, Lee HJ, Jeong EO, Kwon HJ, Kim SH. Role of Adjunctive Tranexamic Acid in Facilitating Resolution of Chronic Subdural Hematoma after Surgery. J Korean Neurosurg Soc. 2023;66(4):446\u201355.","journal-title":"J Korean Neurosurg Soc"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08888-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:43:30Z","timestamp":1749887010000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08888-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8888"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08888-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been ethically approved by the ethic committee of the University of Ulm, Germany, on 15 January 2024 (396\/23-FSt\/Sta). All participants must give their informed written consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent materials {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"207"}}